The Work Index by Flexa

Venova Medical, Inc.

Venova Medical, Inc. is a privately held medical device company developing a next generation percutaneous AVF technology to improve vascular access for hemodialysis patients.

5.7

/10

Transparency ranking

Work at Venova Medical, Inc.?
Show us we're wrong

Description

Venova Medical, Inc. is a privately held medical device company focused on developing innovative solutions for vascular access in hemodialysis patients. They have developed the Velocity System, a next-generation percutaneous arteriovenous fistula (pAVF) technology designed to create a more efficient and durable connection between an artery and a vein, reducing the need for reinterventions and improving outcomes for patients. The company aims to address the challenges associated with conventional methods for vascular access, which often lead to complications and increased healthcare costs.

Venova Medical is currently in the clinical stage of development. They have completed enrollment in a clinical trial to evaluate the safety and feasibility of their Velocity pAVF System. The company has also secured significant funding to support further development of their technology and conduct additional clinical studies in the United States. With their innovative approach and dedicated team, Venova Medical is working towards transforming the standard of care for hemodialysis access.

Mission

Venova Medical, Inc. is a privately held medical device company dedicated to improving vascular access for patients requiring hemodialysis. Their mission is to develop and commercialize innovative, minimally invasive technologies like the Velocity pAVF System, which aims to reduce the need for reinterventions, improve access outcomes, and ultimately provide a more effective and cost-efficient solution for patients with chronic kidney disease.

Disruptor
Healthcare
Improving quality of life/health
Science and research driven

Culture

Venova Medical fosters a collaborative and innovative culture where employees with diverse expertise in medical device development and clinical knowledge come together to address the challenges of providing optimal vascular access for patients on hemodialysis. The company's commitment to improving patient outcomes and reducing healthcare costs is evident in its pursuit of next-generation percutaneous AVF technology, which is reflected in the team's enthusiasm and dedication.

DE&I

Venova Medical's website does not explicitly discuss its approach to diversity, equity, and inclusion. Therefore, I cannot provide a description of their approach based on the provided content.

Other companies